← All diseases Cancer

Mesothelioma

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest level of evidence only (25)Meta-analysis (7)Treatment guideline (2)Systematic review (9)Phase 3 study (5)Randomized trial (2)Clinical trial (594)Review article (165)Early study (phase 1 or 2) (48)Single patient description (165)Laboratory or animal study (30)Commentary or editorial (70)Concerns have been raised (1)Retracted publication (1) Studies currently recruiting participants only (33)

Filter

Publications and studies (1696)

• Pan-cancer Bioinformatics Analysis Combined with Colon Cancer Experimental Validation: A Study on TMED3 as a Diagnostic and Prognostic Biomarker. (2026/07/03) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Networking is Essential for the Proper Management of Rare Cancers: From Recognition to Implementation. (2026/07/02) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. CHIMERA: A Phase II Study of Neoadjuvant Pembrolizumab in Combination With Cisplatin or Carboplatin and Pemetrexed Followed by Surgery and Adjuvant Pembrolizumab in Resectable Pleural Mesothelioma. (2026/07/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Development and validation of artificial intelligence-assisted volumetric response criteria in pleural mesothelioma (ARTIMES): a retrospective, multicohort, multicentre study. (2026/07/01) ♡
• Artificial intelligence volumetry in mesothelioma: ready for deployment? (2026/07/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Outcomes of Platinum Plus Pemetrexed and Treatment Patterns Following First-Line Nivolumab and Ipilimumab in Pleural Mesothelioma: Real-World Results From the German MesoNet Study. (2026/07/01) ♡
• Impact of CD73/CD155 Expression on Survival in Resected Epithelial Pleural Mesothelioma: A Retrospective Single-center Study. (2026/07/01) ♡
• BAP1 Loss Might Be a Predictive Biomarker for Immunotherapy Response in Pleural Mesothelioma. (2026/07/01) ♡
• Protocol for Mesothelioma Observational study of Risk prediction and Generation of paired benign-meso tissue samples, Including a Nested MRI Substudy (Meso-ORIGINS). (2026/07/01) ♡
• From Ascites to Malignant Peritoneal Mesothelioma: The Diagnostic Workup of a Rare Tumor. (2026/07/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Interventional Radiology and Thoracic Oncology: 20 Years of Innovation. (2026/07/01) ♡
• Correction to "Effects of Autophagy Inhibition by SAR405, a Selective VPS34 Inhibitor, on Pleural Mesothelioma Cells". (2026/07/01) ♡
• Promoter reinforcement supports transcriptional resilience in drug-resistant cancer. (2026/07/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Immunohistochemical Loss of MTAP as a Diagnostic and Prognostic Surrogate of CDKN2A/B Homozygous Deletion: A Narrative Review. (2026/07/01) ♡
• Interleukin 32 Expression in Mesothelioma. (2026/07/01) ♡
• AI-assisted Volumetric Response Assessment in Pleural Mesothelioma. (2026/07/01) ♡
• RETRACTED: Zito Marino et al. AXL and MET Tyrosine Kinase Receptors Co-Expression as a Potential Therapeutic Target in Malignant Pleural Mesothelioma. J. Pers. Med. 2022, 12, 1993. (2026/06/30) ♡
• Safety and pathologic response of neoadjuvant pulsed electric field ablation and systemic therapy in early-stage resectable lung cancer: case series. (2026/06/30) ♡
• Divergent roles of PRR11 and HEPACAM in pleural mesothelioma: PRR11 as a prognostic biomarker and HEPACAM as a stage-associated gene with paradoxical expression. (2026/06/30) ♡
• Navigating the Foggy Landscape of Epithelioid Peritoneal Mesothelioma: A Proposed Standardized Institutional Algorithm for Multimodal Management. (2026/06/30) ♡
• Metastatic pleural mesothelioma presenting as ulcerated submucosal colonic nodules. (2026/06/29) ♡
• The epidemiological burden and societal cost of 14 respiratory conditions in the World Health Organization European region: systematic evidence map and economic analysis. (2026/06/29) ♡
• Proliferation of pleural mesothelioma cells is enhanced by the microRNA-197-3p activity. (2026/06/29) ♡
• Prevalence of heterozygous and homozygous 9p21 deletions in human cancer: a tissue microarray study on 4,999 tumors from 125 different tumor types. (2026/06/27) ♡
• Genetic variability of immune checkpoints in asbestos-related diseases. (2026/06/26) ♡
• Systematic total parietal peritonectomy for peritoneal mesothelioma-perioperative and oncological outcomes in an Indian cohort of 100 patients. (2026/06/26) ♡
• Naturally occurring asbestos and its possible environmental and health implications in the Basilicata region (Southern Italy). (2026/06/25) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Cytotoxic and antibacterial potential of Eucalyptus honey: in vitro assessment on human cancer cell lines and bacterial strains. (2026/06/24) ♡
• An analysis of succinate dehydrogenase B in pleural mesothelioma. (2026/06/23) ♡
• CARGO: A Cytometry Analysis framework via Regularized Graph Optimal-transport. (2026/06/23) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case Report: Uterine mesothelial cyst: a report of three cases and literature review. (2026/06/23) ♡
• Trends in malignant mesothelioma incidence in Spain, 1999-2023: a joinpoint and age-period-cohort analysis. (2026/06/22) ♡
• Dual-time-point [(18)F]FDG-PET/CT as a prognostic biomarker in patients with pleural mesothelioma undergoing immunotherapy. (2026/06/20) ♡
• Amivantamab Induces Immune-Mediated Cytotoxicity in Mesothelioma Through EGFR and MET Engagement. (2026/06/20) ♡
• Pericardial Fluid Metastatic Tumor Distribution and Fluid Volume Analysis: A 10-Year Institutional Experience. (2026/06/19) ♡
• FDG PET/CT for Postoperative Surveillance in Malignant Pleural Mesothelioma: Temporal Evolution of Postsurgical Metabolic Activity and Diagnostic Performance for Recurrence Detection. (2026/06/19) ♡
• Doubts have been raisediIn this research, a concern about its accuracy was formally published. It has not been retracted, but there is ongoing doubt about its reliability. Editorial Expression of Concern: Estrogen receptor β activation impairs mitochondrial oxidative metabolism and affects malignant mesothelioma cell growth in vitro and in vivo. (2026/06/18) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Giant intraparenchymal localized mesothelioma: a rare case report. (2026/06/17) ♡
• Multi-omics analysis positions DNA2 at the interface of genome integrity programs and tumor behavior in pan-cancer. (2026/06/17) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Pseudo-Meigs'syndrome mimicking malignant pleural mesothelioma: a case report and diagnostic pitfall analysis. (2026/06/17) ♡
• Background asbestos fiber levels in autopsy lungs: Implications for forensic disease attribution in the post-ban era. (2026/06/16) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case Report: Tislelizumab combined with bevacizumab in the treatment of primary malignant pericardial mesothelioma. (2026/06/16) ♡
• Local Control, Global Strategy: Rethinking the Goals of Surgery for Mesothelioma. (2026/06/15) ♡
• Distinct epidemiologic patterns of mesothelioma: evidence from a 16-year provincial cohort in China. (2026/06/15) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Potential Activity of Non-Platinum Metal-Based Organic Complexes Against Different Cancer Cell Types. (2026/06/12) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Diffuse peritoneal mesothelioma presenting with the appearance of mesenteric panniculitis: A case report. (2026/06/11) ♡
• Fibroblast-like cells in mesothelioma can derive from tumor cells. (2026/06/01) ♡
• Extracellular stressors change BBSome expression of benign mesothelial and primary pleural mesothelioma cells and affect cell adhesion and migration. (2026/06/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Long-Term Disease Control With Second-Line Nivolumab Monotherapy in Malignant Pleural Mesothelioma: A Case Report. (2026/06/01) ♡
• Integrating polygenic and methylation risk scores for pleural mesothelioma risk stratification. (2026/06/01) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.